A century and a half ago, the list of effective cancer treatments was essentially a single entry: surgery. Today, in 2026, you’d need pages to contain the number of treatments available, and multiple notebooks to delineate all of the various therapies currently in development. It is nothing short of a revolution. Of course, no revolution is perfect, and many cancer treatments are ineffective or carry risks of serious side effects. In part 3 of our cancer series, we delve into all facets of cancer treatment, from the history of their development to how they actually work. Tune in to learn how far we’ve come and where we might go from here in our perennial quest to treat and cure cancer.
| History | Biology |
| Mukherjee, Siddhartha. The emperor of all maladies: a biography of cancer. Simon and Schuster, 2010. | Mellman, I., Coukos, G. and Dranoff, G., 2011. Cancer immunotherapy comes of age. Nature, 480(7378), pp.480-489. |
| Ahmad, Amar S., Nick Ormiston-Smith, and Peter D. Sasieni. “Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960.” British journal of cancer 112.5 (2015): 943-947. | Patel, K.K., Tariveranmoshabad, M., Kadu, S., Shobaki, N. and June, C., 2025. From concept to cure: The evolution of CAR-T cell therapy. Molecular Therapy, 33(5), pp.2123-2140. |
| American Cancer Society. Cancer Facts and Figures 2025. Atlanta: American Cancer Society; 2025. | Choucair, K., Imtiaz, H., Uddin, M.H., Nagasaka, M., Al-Hallak, M.N., Philip, P.A., El-Rayes, B., Pasche, B.C. and Azmi, A.S., 2025. Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges. Signal Transduction and Targeted Therapy, 10(1), p.385. |
| Bailar, John C., and Heather L. Gornik. “Cancer undefeated.” New England Journal of Medicine 336.22 (1997): 1569-1574. | Wu, P., Gao, W., Su, M., Nice, E.C., Zhang, W., Lin, J. and Xie, N., 2021. Adaptive mechanisms of tumor therapy resistance driven by tumor microenvironment. Frontiers in cell and developmental biology, 9, p.641469. |
| Hajdu, Steven I. “Pathfinders in oncology from ancient times to the end of the Middle Ages.” Cancer 122.11 (2016): 1638-1646. | Hanna, T.P., King, W.D., Thibodeau, S., Jalink, M., Paulin, G.A., Harvey-Jones, E., O’Sullivan, D.E., Booth, C.M., Sullivan, R. and Aggarwal, A., 2020. Mortality due to cancer treatment delay: systematic review and meta-analysis. bmj, 371. |
| Hajdu, Steven I. “A note from history: landmarks in history of cancer, part 1.” Cancer 117.5 (2011): 1097-1102. | Farkona, S., Diamandis, E.P. and Blasutig, I.M., 2016. Cancer immunotherapy: the beginning of the end of cancer?. BMC medicine, 14(1), p.73. |
| Hajdu, Steven I. “A note from history: landmarks in history of cancer, part 2.” Cancer 117.12 (2011): 2811-2820. | Tsimberidou, A.M., Fountzilas, E., Nikanjam, M. and Kurzrock, R., 2020. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer treatment reviews, 86, p.102019. |
| Hajdu, Steven I. “A note from history: landmarks in history of cancer, part 3.” Cancer 118.4 (2012): 1155-1168. | Debela, D.T., Muzazu, S.G., Heraro, K.D., Ndalama, M.T., Mesele, B.W., Haile, D.C., Kitui, S.K. and Manyazewal, T., 2021. New approaches and procedures for cancer treatment: Current perspectives. SAGE open medicine, 9, p.20503121211034366. |
| Hajdu, Steven I. “A note from history: landmarks in history of cancer, part 4.” Cancer 118.20 (2012): 4914-4928. | Chandra, R.A., Keane, F.K., Voncken, F.E. and Thomas, C.R., 2021. Contemporary radiotherapy: present and future. The Lancet, 398(10295), pp.171-184. |
| Hajdu, Steven I., and Farbod Darvishian. “A note from history: landmarks in history of cancer, part 5.” Cancer 119.8 (2013): 1450-1466. | Taheri, A., Vishwanath, V., Wong, J.J., Price, P. and Rembielak, A., 2020. The use of imaging and interventional radiology in modern oncology. Medicine, 48(2), pp.73-78. |
| Hajdu, Steven I., and Manjunath Vadmal. “A note from history: Landmarks in history of cancer, Part 6.” Cancer 119.23 (2013): 4058-4082. | Gatenby, R.A., Silva, A.S., Gillies, R.J. and Frieden, B.R., 2009. Adaptive therapy. Cancer research, 69(11), pp.4894-4903. |
| Hajdu, Steven I., Manjunath Vadmal, and Ping Tang. “A note from history: Landmarks in history of cancer, part 7.” Cancer 121.15 (2015): 2480-2513. | Mukherjee, U.A., Hockings, H., Counsell, N., Patel, A., Narayanan, P., Wilkinson, K., Dhanda, H., Robinson, K., McNeish, I., Anderson, A.R. and Miller, R., 2024. Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer. BMJ open, 14(12), p.e091262. |
| Kampen, Kim R. “The discovery and early understanding of leukemia.” Leukemia research 36.1 (2012): 6-13. | Cappell, K.M. and Kochenderfer, J.N., 2023. Long-term outcomes following CAR T cell therapy: what we know so far. Nature reviews Clinical oncology, 20(6), pp.359-371. |
| Abshire, Dorothy, and Matthew K. Lang. “The evolution of radiation therapy in treating cancer.” Seminars in oncology nursing. Vol. 34. No. 2. WB Saunders, 2018. | Kim, E., Brown, J.S., Eroglu, Z. and Anderson, A.R., 2021. Adaptive therapy for metastatic melanoma: predictions from patient calibrated mathematical models. Cancers, 13(4), p.823. |
| Connell, Philip P., and Samuel Hellman. “Advances in radiotherapy and implications for the next century: a historical perspective.” Cancer research 69.2 (2009): 383-392. | Hockings, H., Lakatos, E., Huang, W., Mossner, M., Khan, M.A., Bakali, N., McDermott, J., Smith, K., Baker, A.M., Graham, T.A. and Lockley, M., 2025. Adaptive therapy exploits fitness deficits in chemotherapy-resistant ovarian cancer to achieve long-term tumor control. Cancer Research, 85(18), pp.3503-3517. |
| Cooper, William A. “The history of the radical mastectomy.” Annals of medical history 3.1 (1941): 36. | Brady-Nicholls, R. and Enderling, H., 2022. Range-bounded adaptive therapy in metastatic prostate cancer. Cancers, 14(21), p.5319. |
| Debela, Dejene Tolossa, et al. “New approaches and procedures for cancer treatment: Current perspectives.” SAGE open medicine 9 (2021): 20503121211034366. | Haroun, R., Wood, J.N. and Sikandar, S., 2023. Mechanisms of cancer pain. Frontiers in Pain Research, 3, p.1030899. |
| DeVita Jr, Vincent T., and Edward Chu. “A history of cancer chemotherapy.” Cancer research 68.21 (2008): 8643-8653. | Al Maqrashi, Z.A.A., Chan, S.W.S., Siddiqui, Z. and Dotan, E., 2025. Oncology: what you may have missed in 2024. Annals of internal medicine, 178(5), pp.S89-S109. |
| Dobosz, Paula, and Tomasz Dzieciątkowski. “The intriguing history of cancer immunotherapy.” Frontiers in immunology 10 (2019): 2965. | Waks, A.G. and Winer, E.P., 2019. Breast cancer treatment: a review. Jama, 321(3), pp.288-300. |
| Galmarini, Darío, Carlos M. Galmarini, and Felipe C. Galmarini. “Cancer chemotherapy: a critical analysis of its 60 years of history.” Critical reviews in oncology/hematology 84.2 (2012): 181-199. | Meng, Y., Zhang, Q., Wu, R., Li, H., Wang, Z., Yao, Y., Li, X., Chen, Z., Gong, Y. and Liu, H., 2024. Efficacy and safety of perioperative, neoadjuvant, or adjuvant immunotherapy alone or in combination with chemotherapy in early-stage non-small cell lung cancer: a systematic review and meta-analysis of randomized clinical trials. Therapeutic Advances in Medical Oncology, 16, p.17588359241284929. |
| Hayter, Charles RR. “The clinic as laboratory: The case of radiation therapy, 1896-1920.” Bulletin of the History of Medicine 72.4 (1998): 663-688. | Guan, W.L., He, Y. and Xu, R.H., 2023. Gastric cancer treatment: recent progress and future perspectives. Journal of hematology & oncology, 16(1), p.57. |
| Lawrence, Walter, and Marvin J. Lopez. “Radical surgery for cancer: a historical perspective.” Surgical Oncology Clinics 14.3 (2005): 441-446. | Biller, L.H. and Schrag, D., 2021. Diagnosis and treatment of metastatic colorectal cancer: a review. Jama, 325(7), pp.669-685. |
| Leszczynski, Konrad, and Susan Boyko. “On the controversies surrounding the origins of radiation therapy.” Radiotherapy and oncology 42.3 (1997): 213-217. | Farhangnia, P., Khorramdelazad, H., Nickho, H. and Delbandi, A.A., 2024. Current and future immunotherapeutic approaches in pancreatic cancer treatment. Journal of Hematology & Oncology, 17(1), p.40. |
| Sakorafas, G. H., and Michael Safioleas. “Breast cancer surgery: an historical narrative. Part II. 18th and 19th centuries.” European journal of cancer care 19.1 (2010): 6-29. | Labrie, M., Brugge, J.S., Mills, G.B. and Zervantonakis, I.K., 2022. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nature Reviews Cancer, 22(6), pp.323-339. |
| Sakorafas, G. H., and Michael Safioleas. “Breast cancer surgery: an historical narrative. Part III. From the sunset of the 19th to the dawn of the 21st century.” European Journal of Cancer Care 19.2 (2010): 145-166. | Taylor, S.R., Falcone, J.N., Cantley, L.C. and Goncalves, M.D., 2022. Developing dietary interventions as therapy for cancer. Nature Reviews Cancer, 22(8), pp.452-466. |
| Schaue, Dörthe. “A century of radiation therapy and adaptive immunity.” Frontiers in immunology 8 (2017): 431. | Sathianathen, N.J., Konety, B.R., Crook, J., Saad, F. and Lawrentschuk, N., 2018. Landmarks in prostate cancer. Nature Reviews Urology, 15(10), pp.627-642. |
| Widder, Joachim. “The origins of radiotherapy: Discovery of biological effects of X-rays by Freund in 1897, Kienböck’s crucial experiments in 1900, and still it is the dose.” Radiotherapy and Oncology 112.1 (2014): 150-152. | Ro, C., The economic effects of federal cuts to US science-in 24 graphs. Nature. |
| Wyld, Lynda, Riccardo A. Audisio, and Graeme J. Poston. “The evolution of cancer surgery and future perspectives.” Nature reviews Clinical oncology 12.2 (2015): 115-124. | Nienaber, V. and Leeming, J., 2025. What research might be lost after the NIH’s cuts? Nature trained a bot to find out. Nature. |
| Schlossberg. Nov 2025. A battle with my blood. The New Yorker. https://www.newyorker.com/culture/the-weekend-essay/a-battle-with-my-blood |
Disclaimer: This post may contain affiliate links. If you buy something through one of these links, you won’t pay a penny more, but we’ll get a small commission which helps us keep things running. Thanks!